Long-acting insulin analogue therapy initiation and follow-up by healthcare practitioners in patients with type 2 diabetes mellitus uncontrolled with oral antidiabetic drugs: the LIGHT Study

被引：0
|
作者：
Verges, B. [1 ]
Brun, J. -M. [1 ]
Tawil, C.
Alexandre, B. [2 ]
Kerlan, V. [3 ]
机构：
[1] CHU Dijon, Hop Bocage, Serv Endocrinol, Paris, France
[2] Novo Nordisk Pharmaceut, Med Affairs, Paris, France
[3] CHU La Cavale Blanche, Brest, France
来源：
DIABETOLOGIA | 2009年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
972
引用
收藏
页码：S382 / S382
页数：1
相关论文
共 50 条
  • [41] A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus
    Nowotny, B.
    DIABETOLOGE, 2010, 6 (01): : 50 - 50
  • [42] HbA1c Reduction after Initiation of the FreeStyle Libre System in Type 2 Diabetes Patients on Long-Acting Insulin or Noninsulin Therapy
    Miller, Eden
    Brandner, Laura
    Wright, Eugene, Jr.
    DIABETES, 2020, 69
  • [43] Exenatide compared with long acting insulin to achieve glycaemic control with minimal weight gain in patients with type 2 diabetes mellitus: results of the Helping Evaluate Exenatide in patients with diabetes compared to Long-Acting insulin (HEELA) study
    Davies, M. J.
    Donnelly, R.
    Barnett, A. H.
    Jones, S.
    Nicolay, C.
    Kilcoyne, A.
    DIABETOLOGIA, 2009, 52 : S290 - S290
  • [44] Novel long-acting basal insulin analogue LY2605541 significantly reduces nocturnal hypoglycaemia and fear of hypoglycaemia compared to insulin glargine in patients with type 2 diabetes mellitus
    Curtis, B.
    Shi, C.
    DIABETOLOGIA, 2012, 55 : S392 - S392
  • [45] The association of diabetes mellitus treated with oral antidiabetic drugs and insulin with mortality after transcatheter valve implantation: a 3-year follow-up of the TAVIK registry
    Panagiotis Tzamalis
    Valentin Herzberger
    Jens Bergmann
    Alexander Wuerth
    Peter Bramlage
    Holger Schroefel
    Claus Schmitt
    Gerhard Schymik
    Cardiovascular Diabetology, 18
  • [46] The association of diabetes mellitus treated with oral antidiabetic drugs and insulin with mortality after transcatheter valve implantation: a 3-year follow-up of the TAVIK registry
    Tzamalis, Panagiotis
    Herzberger, Valentin
    Bergmann, Jens
    Wuerth, Alexander
    Bramlage, Peter
    Schroefel, Holger
    Schmitt, Claus
    Schymik, Gerhard
    CARDIOVASCULAR DIABETOLOGY, 2019, 18 (1)
  • [47] PHARMACOECONOMICS MODELING OF LONG TERM RESULTS OF TYPE 2 DIABETES MELLITUS TREATMENT IN PATIENTS USING MODERN INSULIN ANALOGUES IN CONTRAST TO ORAL ANTIDIABETIC DRUGS OR DIET
    Yagudina, R.
    Kulikov, A. U.
    Arinina, E. E.
    VALUE IN HEALTH, 2010, 13 (07) : A292 - A292
  • [48] Direct healthcare costs of patients with type 2 diabetes using long-acting insulin analogues or NPH insulin in a basal insulin-only regimen
    Gundgaard, Jens
    Christensen, Torsten E.
    Thomsen, Trine Lyager
    PRIMARY CARE DIABETES, 2010, 4 (03) : 165 - 172
  • [49] Type 2 diabetes: introduction and follow-up of insulin therapy by slow analog in 2541 patients with non-controlled type 2 diabetes by oral antidiabetics in a general medicine and diabetology consultation. LIGHT study
    Verges, B.
    Brun, J. M.
    Kerlan, V.
    Tawil, C.
    Leutenegger, E.
    Alexandre, B.
    Gonbert, S.
    DIABETES & METABOLISM, 2009, 35 : A51 - A51
  • [50] Clinical outcomes of basal insulin and oral antidiabetic agents as an add-on to dual therapy in patients with type 2 diabetes mellitus
    Chih-Ning Cheng
    Chih-Yuan Wang
    Hung-Wei Lin
    Ting-Yu Chang
    Hsu-Ju Lin
    Chiahung Chou
    Fang-Ju Lin
    Scientific Reports, 10
12345